Daniele Giacoppo

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Stay updated with the latest in interventional cardiology at #ESCCongress 2025!

Gain insights into emerging prognostic predictors for coronary artery disease patients, including endothelial shear stress as a cardiovascular risk marker, impacts of intravascular imaging stratified by disease pattern, correlations between diastolic blood pressure and SYNTAX score, and long-term wall shear stress risk prediction from the FAME...

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2025 Scientific Sessions #ACC25

Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2024 - check out the list below.

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

What was new and hot in interventional cardiology at #ESCCongress 2024!

This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on procedural techniques for the management of calcified coronary lesions. It will feature various complex cases, including in-stent shave and debulk, damned coronary nodules, rotatripsy burring before the shock, protected high-risk PCI of a heavily calcified...

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2024 Scientific Sessions #ACC24

Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)

What was new and hot in interventional cardiology at #ESCCongress 2023!

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

This patient-level analysis of randomized trials comparing PCI vs CABG for the treatment of low-to-intermediate CAD involving the LM confirms the absence of long-term differences in mortality between revascularization techniques, regardless of the clinical presentation.

Watch this serie of commented cases focusing on PCI of calcified lesions and develop your expertise in treating situations that often remain a challenge. Selected cases cover right coronary artery in Sherpherd's crook, intravascular lithotripsy and much more.

If you would like to learn more about the latest findings on stent techhnology, check-out this session in which speakers reviewed a series of recent trials, among them: 12-month primary endpoint outcomes of the BIOADAPTOR-RCT; Final 5-year results from the blinded ABSORB IV trial ; BIOMAG-I:...

Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology / World Heart Federation 2023 Scientific Sessions #ACC23 #WCCardio.

Stay up to date with what is new and hot in interventional cardiology at #AHA22 in Chicago.

Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Stay up to date with what was new and hot in interventional cardiology at the #ESCCongress 2022!

The UK TAVI trial sought to compare TAVI with SAVR in patients with severe, symptomatic aortic stenosis and moderately increased surgical risk.

Let's study, LIVE from Massy, France, the case of a 76-year-old man, hypertensive, dyslipidemic, who presented apical necrosis without ischemia in 2017, asymptomatic, referred for myocardial scintigraphy, and find out more about performing LM PCI, using imaging to guide the procedure.

Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability of the FAME 3 trial presented at TCT 2021.

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Make sure you stay up to date with what's new and hot in interventional cardiology at this year's #ESCCongress!